Thursday, November 21, 2024
Subscribe American Journal of Medicine Free Newsletter
CardiologyCME: Pharmacological Cardiac Stress Testing

CME: Pharmacological Cardiac Stress Testing

Cardiac Stress TestingThe American Journal of Medicine and The American Journal of Cardiology are offering a new online continuing medical education (CME) course: Update on Pharmalogical Cardiac Stress Testing: Efficacy, Risk Stratification, and Patient Selection.

Program Overview

Given the rapidly evolving field of cardiac stress testing with respect to new risk stratification algorithms, new agents, and new assessment methods, it is difficult for physicians to remain up to date on the latest research and the benefits and risks of different testing modalities. This CME activity provides an overview on the indications and guidelines for testing for coronary heart disease. A panel of experts discuss evidence-based data and exercise practical implications for clinical decision-making. This educational intervention will bring clinicians a current understanding of patient-centered cardiovascular imaging to improve the individualized management of patients with suspected coronary heart disease.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the factors and guidelines for risk stratification and patient selection when ordering a pharmacological cardiac stress test, including the pre-operative assessment.
  2. Analyze recent clinical trial data concerning the application of pharmacologic agents used to induce cardiac stress, as well as state-of-the-art diagnostic imaging techniques.
  3. Improve communication between internists and cardiologists to order the right cardiac stress test for the right patients.
  4. Implement patient education and communication strategies that involve the patient in the decision-making process and prepare the patient for cardiac stress testing

For registration and login, go here.

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...